Literature DB >> 21800152

Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.

Helen A Blacker1, Sandra Orgeig.   

Abstract

Lymphangiogenesis, the growth of new lymph vessels, has important roles in both normal and pathological lymphatic function. Despite recent advances, the precise molecular mechanisms behind the lymphangiogenic process remain unclear. The Australian marbled gecko, Christinus marmoratus, voluntarily drops its tail (autotomy) as a predator avoidance strategy. Following autotomy a new tail is regenerated including lymphatic drainage pathways. We examined the molecular control of lymphangiogenesis within the unique model of the regenerating gecko tail. Partial sequences were obtained of the gecko lymphangiogenic growth factors, vascular endothelial growth factor C (VEGF-C) and VEGF-D along with their receptor VEGFR-3. These were highly homologous to other vertebrates. Quantitative real-time polymerase chain reaction (PCR) demonstrated up-regulation of VEGF-C, VEGF-D and VEGFR-3 mRNA expression during the early and middle stages of tail regeneration (between 4 and 9 weeks following autotomy), in late regeneration (12 weeks) and during mid-regeneration (7 and 9 weeks), respectively. VEGF-C and VEGF-D immunostaining was observed lining some lymphatic-like and blood vessels in early-mid tail regeneration, indicating possible associations of the proteins with VEGFRs on endothelia. Keratinocytes and fibroblasts also showed positive staining of VEGF-C and VEGF-D in early-mid tail regeneration. Additionally, VEGF-C was localised in adipose tissue in all tail states examined. This work suggests that specific timings exist for the expression of the lymphangiogenic growth factors, VEGF-C and VEGF-D, and their receptor, VEGF-R3, throughout the regeneration of a functional lymphatic network. Along with localisation data, this suggests potential functions for the growth factors in lymphangiogenesis and angiogenesis throughout tail regeneration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800152     DOI: 10.1007/s00360-011-0604-0

Source DB:  PubMed          Journal:  J Comp Physiol B        ISSN: 0174-1578            Impact factor:   2.200


  61 in total

1.  Vascular endothelial growth factor-C accelerates diabetic wound healing.

Authors:  Anne Saaristo; Tuomas Tammela; Anniina Farkkilā; Marika Kärkkäinen; Erkki Suominen; Seppo Yla-Herttuala; Kari Alitalo
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

2.  Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo.

Authors:  Tatiana V Byzova; Corey K Goldman; Jurek Jankau; Juhua Chen; Gustavo Cabrera; Marc G Achen; Steven A Stacker; Kevin A Carnevale; Maria Siemionow; Steven R Deitcher; Paul E DiCorleto
Journal:  Blood       Date:  2002-06-15       Impact factor: 22.113

3.  VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

Authors:  R Valtola; P Salven; P Heikkilä; J Taipale; H Joensuu; M Rehn; T Pihlajaniemi; H Weich; R deWaal; K Alitalo
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

4.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Authors:  Young-Sup Yoon; Toshinori Murayama; Edwin Gravereaux; Tengiz Tkebuchava; Marcy Silver; Cynthia Curry; Andrea Wecker; Rudolf Kirchmair; Chun Song Hu; Marianne Kearney; Alan Ashare; David G Jackson; Hajime Kubo; Jeffrey M Isner; Douglas W Losordo
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin.

Authors:  B Enholm; T Karpanen; M Jeltsch; H Kubo; F Stenback; R Prevo; D G Jackson; S Yla-Herttuala; K Alitalo
Journal:  Circ Res       Date:  2001-03-30       Impact factor: 17.367

6.  Vascular endothelial growth factor-D expression in human atherosclerotic lesions.

Authors:  Juha Rutanen; Pia Leppänen; Tiina T Tuomisto; Tuomas T Rissanen; Mikko O Hiltunen; Ismo Vajanto; Mari Niemi; Tomi Häkkinen; Kari Karkola; Steven A Stacker; Marc G Achen; Kari Alitalo; Seppo Ylä-Herttuala
Journal:  Cardiovasc Res       Date:  2003-10-01       Impact factor: 10.787

7.  Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle.

Authors:  Andrey Anisimov; Annamari Alitalo; Petra Korpisalo; Jarkko Soronen; Seppo Kaijalainen; Veli-Matti Leppänen; Michael Jeltsch; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

8.  Expression of VEGFR-3 and 5'-nase in regenerating lymphatic vessels of the cutaneous wound healing.

Authors:  Rui-Cheng Ji; Masahiro Miura; Peng Qu; Seiji Kato
Journal:  Microsc Res Tech       Date:  2004-06-15       Impact factor: 2.769

Review 9.  The link between lymphatic function and adipose biology.

Authors:  Natasha L Harvey
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

10.  VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development.

Authors:  E Kukk; A Lymboussaki; S Taira; A Kaipainen; M Jeltsch; V Joukov; K Alitalo
Journal:  Development       Date:  1996-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.